<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>&lt;em&gt;CFTR&lt;/em&gt; gene mutations approved for each type of CFTR modulator therapy</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center"><em>CFTR</em> gene mutations approved for each type of CFTR modulator therapy</h1>
<div class="graphic"><div class="figure"><div class="ttl"><em>CFTR</em> gene mutations approved for each type of CFTR modulator therapy</div><div class="cntnt"><table cellspacing="0"><colgroup span="6" width="16%"></colgroup> <tbody> <tr> <td class="highlight_lght_green_text">546insCTA</td> <td class="highlight_lght_green_text">E403D</td> <td>G628R</td> <td class="highlight_lght_green_text">L346P</td> <td class="highlight_green_text">R117H</td> <td class="highlight_lght_green_text">S912L</td> </tr> <tr> <td class="highlight_seagreen_text">711+3A&gt;G</td> <td>E474K</td> <td class="highlight_green_text">G970D</td> <td>L453S</td> <td class="highlight_green_text">R117L</td> <td class="highlight_green_text">S945L</td> </tr> <tr> <td class="highlight_seagreen_text">2789+5G&gt;A</td> <td class="highlight_lght_green_text">E588V</td> <td>G1061R</td> <td class="highlight_green_text">L967S</td> <td class="highlight_green_text">R117P</td> <td class="highlight_green_text">S977F</td> </tr> <tr> <td>3141del9</td> <td class="highlight_green_text">E822K</td> <td class="highlight_green_text">G1069R</td> <td class="highlight_green_text">L997F</td> <td class="highlight_green_text">R170H</td> <td class="highlight_green_text">S1159F</td> </tr> <tr> <td class="highlight_seagreen_text">3272-26A&gt;G</td> <td class="highlight_seagreen_text">E831X</td> <td class="highlight_green_text">G1244E</td> <td>L1077P</td> <td class="highlight_lght_green_text">R258G</td> <td class="highlight_green_text">S1159P</td> </tr> <tr> <td class="highlight_seagreen_text">3849+10kbC&gt;T</td> <td class="highlight_lght_green_text">F191V</td> <td class="highlight_green_text">G1249R</td> <td class="highlight_lght_green_text">L1324P</td> <td class="highlight_lght_green_text">R334L</td> <td class="highlight_green_text">S1251N</td> </tr> <tr> <td>A46D</td> <td class="highlight_green_text">F311del</td> <td class="highlight_green_text">G1349D</td> <td class="highlight_lght_green_text">L1335P</td> <td class="highlight_lght_green_text">R334Q</td> <td class="highlight_green_text">S1255P</td> </tr> <tr> <td class="highlight_green_text">A120T</td> <td class="highlight_green_text">F311L</td> <td>H139R</td> <td class="highlight_green_text">L1480P</td> <td class="highlight_green_text">R347H</td> <td class="highlight_green_text">T338I</td> </tr> <tr> <td class="highlight_green_text">A234D</td> <td class="highlight_green_text">F508C</td> <td>H199Y</td> <td class="highlight_green_text">M152V</td> <td class="highlight_green_text">R347L</td> <td class="highlight_lght_green_text">T1036N</td> </tr> <tr> <td class="highlight_green_text">A349V</td> <td class="highlight_green_text">F508C;S1251N</td> <td class="highlight_green_text">H939R</td> <td class="highlight_lght_green_text">M265R</td> <td class="highlight_lght_green_text">R347P</td> <td class="highlight_green_text">T1053I</td> </tr> <tr> <td class="highlight_green_text">A455E</td> <td class="highlight_lght_green_text"><strong>F508del</strong>*</td> <td class="highlight_lght_green_text">H1054D</td> <td class="highlight_green_text">M952I</td> <td class="highlight_green_text">R352Q</td> <td class="highlight_lght_green_text">V201M</td> </tr> <tr> <td class="highlight_lght_green_text">A554E</td> <td class="highlight_lght_green_text">F575Y</td> <td>H1085P</td> <td class="highlight_green_text">M952T</td> <td class="highlight_lght_green_text">R352W</td> <td class="highlight_green_text">V232D</td> </tr> <tr> <td class="highlight_lght_green_text">A1006E</td> <td class="highlight_lght_green_text">F1016S</td> <td>H1085R</td> <td>M1101K</td> <td class="highlight_green_text">R553Q</td> <td>V456A</td> </tr> <tr> <td class="highlight_green_text">A1067T</td> <td class="highlight_green_text">F1052V</td> <td class="highlight_green_text">H1375P</td> <td class="highlight_lght_green_text">P5L</td> <td class="highlight_green_text">R668C</td> <td>V456F</td> </tr> <tr> <td class="highlight_green_text">D110E</td> <td class="highlight_green_text">F1074L</td> <td class="highlight_green_text">I148T</td> <td class="highlight_green_text">P67L</td> <td class="highlight_lght_green_text">R751L</td> <td class="highlight_green_text">V562I</td> </tr> <tr> <td class="highlight_green_text">D110H</td> <td class="highlight_lght_green_text">F1099L</td> <td class="highlight_green_text">I175V</td> <td class="highlight_lght_green_text">P205S</td> <td class="highlight_green_text">R792G</td> <td class="highlight_green_text">V754M</td> </tr> <tr> <td class="highlight_green_text">D192G</td> <td>G27R</td> <td class="highlight_lght_green_text">I336K</td> <td>P574H</td> <td class="highlight_green_text">R933G</td> <td class="highlight_lght_green_text">V1153E</td> </tr> <tr> <td class="highlight_lght_green_text">D443Y</td> <td>G85E</td> <td>I502T</td> <td class="highlight_lght_green_text">Q98R</td> <td class="highlight_lght_green_text">R1066H</td> <td class="highlight_lght_green_text">V1240G</td> </tr> <tr> <td class="highlight_lght_green_text">D443Y;G576A;R668C</td> <td class="highlight_lght_green_text">G126D</td> <td class="highlight_lght_green_text">I601F</td> <td class="highlight_green_text">Q237E</td> <td class="highlight_green_text">R1070Q</td> <td class="highlight_green_text">V1293G</td> </tr> <tr> <td class="highlight_green_text">D579G</td> <td class="highlight_green_text">G178E</td> <td class="highlight_lght_green_text">I618T</td> <td class="highlight_green_text">Q237H</td> <td class="highlight_green_text">R1070W</td> <td>W361R</td> </tr> <tr> <td class="highlight_lght_green_text">D614G</td> <td class="highlight_green_text">G178R</td> <td class="highlight_green_text">I807M</td> <td class="highlight_green_text">Q359R</td> <td class="highlight_green_text">R1162L</td> <td>W1098C</td> </tr> <tr> <td class="highlight_lght_green_text">D836Y</td> <td class="highlight_green_text">G194R</td> <td class="highlight_lght_green_text">I980K</td> <td class="highlight_green_text">Q1291R</td> <td class="highlight_green_text">R1283M</td> <td class="highlight_green_text">W1282R</td> </tr> <tr> <td class="highlight_green_text">D924N</td> <td class="highlight_lght_green_text">G194V</td> <td class="highlight_green_text">I1027T</td> <td class="highlight_lght_green_text">R31L</td> <td class="highlight_lght_green_text">R1283S</td> <td class="highlight_lght_green_text">Y109N</td> </tr> <tr> <td class="highlight_lght_green_text">D979V</td> <td class="highlight_green_text">G314E</td> <td class="highlight_green_text">I1139V</td> <td class="highlight_lght_green_text">R74Q</td> <td>S13F</td> <td>Y161D</td> </tr> <tr> <td class="highlight_green_text">D1152H</td> <td>G463V</td> <td class="highlight_lght_green_text">I1269N</td> <td class="highlight_green_text">R74W</td> <td>S341P</td> <td class="highlight_lght_green_text">Y161S</td> </tr> <tr> <td class="highlight_green_text">D1270N</td> <td>G480C</td> <td class="highlight_lght_green_text">I1366N</td> <td class="highlight_lght_green_text">R74W;D1270N</td> <td>S364P</td> <td>Y563N</td> </tr> <tr> <td class="highlight_green_text">E56K</td> <td class="highlight_green_text">G551D</td> <td class="highlight_green_text">K1060T</td> <td class="highlight_lght_green_text">R74W;V201M</td> <td>S492F</td> <td class="highlight_green_text">Y1014C</td> </tr> <tr> <td class="highlight_lght_green_text">E60K</td> <td class="highlight_green_text">G551S</td> <td class="highlight_lght_green_text">L15P</td> <td class="highlight_lght_green_text">R74W;V201M;D1270N</td> <td class="highlight_green_text">S549N</td> <td class="highlight_green_text">Y1032C</td> </tr> <tr> <td class="highlight_lght_green_text">E92K</td> <td class="highlight_green_text">G576A</td> <td>L165S</td> <td class="highlight_green_text">R75Q</td> <td class="highlight_green_text">S549R</td> <td> </td> </tr> <tr> <td class="highlight_lght_green_text">E116K</td> <td class="highlight_lght_green_text">G576A;R668C</td> <td class="highlight_green_text">L206W</td> <td class="highlight_green_text">R117C</td> <td class="highlight_green_text">S589N</td> <td> </td> </tr> <tr class="divider_bottom"> <td class="highlight_green_text">E193K</td> <td class="highlight_lght_green_text">G622D</td> <td class="highlight_green_text">L320V</td> <td class="highlight_green_text">R117G</td> <td class="highlight_green_text">S737F</td> <td> </td> </tr> <tr class="divider_bottom"> <td class="highlight_gray_text" colspan="6"> </td> </tr> <tr> <td colspan="6"><strong>Color key:</strong></td> </tr> <tr> <td class="indent1" colspan="6"><span class="primarybox_key highlight_green_text"> </span> Approved for ELX-TEZ-IVA, TEZ-IVA, and IVA</td> </tr> <tr> <td class="indent1" colspan="6"><span class="primarybox_key highlight_lght_green_text"> </span> Approved for ELX-TEZ-IVA and TEZ-IVA</td> </tr> <tr> <td class="indent1" colspan="6"><span class="primarybox_key"> </span> Approved for ELX-TEZ-IVA only</td> </tr> <tr> <td class="indent1" colspan="6"><span class="primarybox_key highlight_seagreen_text"> </span> Approved for IVA and TEZ-IVA but not ELX-TEZ-IVA<sup>¶</sup></td> </tr> </tbody></table></div><div class="graphic_lgnd">A patient is eligible for ELX-TEZ-IVA if they have 1 or more of the above mutations (except for the 5 mutations noted), with any disease-causing mutation at the other allele. In general, if a patient has a genotype that is eligible for more than 1 therapy, we suggest starting on the maximal therapy available for their age group (ie, triple therapy &gt; dual therapy &gt; monotherapy). As of May 2023, IVA is approved in the United States for children ≥1 month old, ELX-TEZ-IVA for ≥2 years, and TEZ-IVA for ≥6 years.</div><div class="graphic_footnotes"><p>CFTR: cystic fibrosis transmembrane conductance regulator; ELX-TEZ-IVA (ETI): elexacaftor-tezacaftor-ivacaftor; TEZ-IVA: tezacaftor-ivacaftor; IVA: ivacaftor, LUM-IVA: lumacaftor-ivacaftor.</p>
* F508del is the most common <em>CFTR</em> gene mutation in most populations. Drug eligibility considerations are:
<ul>
<li>F508del heterozygotes – To be eligible for ELX-TEZ-IVA, only 1 copy of F508del is required. To be eligible for TEZ-IVA, patients must have 2 copies of a responsive mutation (eg, F508del with any other responsive mutation on the other allele).</li>
<li>F508del homozygotes – Patients who are homozygotes for F508del are eligible for several drug combinations. We recommend triple therapy (ETI) rather than dual therapy (TEZ-IVA or LUM-IVA) as soon as they reach an eligible age for ETI (≥2 years). We suggest LUM-IVA for children ages 1 to &lt;2 years.</li>
</ul>
<p class="extra_spacing_top">¶ ELX-TEZ-IVA has not been approved for use in these 5 "splice site" mutations, because the assay used as a predictor of efficacy is not valid for this type of mutation. Clinical studies of ELX-TEZ-IVA have not included sufficient numbers of patients with these rare mutations to assess efficacy in this population. However, the demonstrated efficacy of IVA and TEZ-IVA for patients with these mutations suggests that ELX-TEZ-IVA would also be effective.</p></div><div class="graphic_reference">Data from:
<ol>
<li>KALYDECO® (ivacaftor) Tablets and Oral Granules. Vertex Pharmaceuticals Incorporated. <a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/207925s016lbl.pdf" target="_blank">https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/207925s016lbl.pdf</a> (Accessed on May 9 2023).</li>
<li>SYMDEKO® (tezacaftor/ivacaftor; ivacaftor) Tablets. Vertex Pharmaceuticals Incorporated. <a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/210491s007lbl.pdf" target="_blank">https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/210491s007lbl.pdf</a> (Accessed on December 20, 2020).</li>
<li> TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor; ivacaftor) Tablets and Oral Granules. Vertex Pharmaceuticals Incorporated. <a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217660s000lbl.pdf" target="_blank">https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217660s000lbl.pdf</a> (Accessed on April 29, 2023).</li>
</ol></div><div id="graphicVersion">Graphic 130494 Version 9.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
